Heartseed Inc. (219A.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

396.8x

EV/EBITDA

−58.2x

Market Cap

JPY 48.97B

MomentumView details →

1D Return

−2.29%

YTD Return

+23.95%

RSI (14)

56.9

ValuationView details →

P/E (Fwd)

396.8x

EV/EBITDA

−58.2x

Market Cap

JPY 48.97B

RSI (14)

56.9

MomentumView details →

1D Return

−2.29%

YTD Return

+23.95%

ProfitabilityView details →

Gross Margin

100.02%

Net Margin

6.28%

EBITDA Margin

10.74%

ROE (TTM)

2.64%

ROA (TTM)

2.48%

Asset Turnover

0.39x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+246.62%

EPS CAGR 3Y

+117.07%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

22.30x

Quick Ratio

22.30x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

3.01B

Net Income (TTM)

610.00M

Op. CF (TTM)

—

Next earningsDec 2, 2026 →

Latest newsMore news →

Heartseed announced clinical trial results for its iPS cell-derived cardiomyocyte product for heart failure, confirming efficacy and safety, and aims to file for approval within the year.4d ago

Heartseed applied to the Tokyo Metropolitan Government for a manufacturing and sales license for regenerative medicine products.18d ago

Similar companies

TAUNS Laboratories,Inc.197A.T Cuorips Inc.4894.T Fuji Pharma Co.,Ltd.4554.T ASKA Pharmaceutical Holdings Co.,Ltd.4886.T Daito Pharmaceutical Co.,Ltd.4577.T SEIKAGAKU CORPORATION4548.T Find similar companies →

Latest newsMore news →

Heartseed announced clinical trial results for its iPS cell-derived cardiomyocyte product for heart failure, confirming efficacy and safety, and aims to file for approval within the year.4d ago Heartseed applied to the Tokyo Metropolitan Government for a manufacturing and sales license for regenerative medicine products.18d ago